Crossmark

Extrapolation of in vitro effect concentrations to in vivo bioavailable concentrations using PBK modelling in humans for two classes of persistent and mobile compounds: triazoles and triazines

Crossref DOI link: https://doi.org/10.1007/s00204-025-04268-w

Published Online: 2026-02-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ravi Shankar, Abishek Laxmanan

Irwan, Jenny

Spaenig, Max

Carlier, Maxim

Hansen, Tanja

Zumbülte, Nicole

Islam, Barira

Lundquist, Patrik

Svensson, Richard

Gouin, Todd

Hamers, Timo

Escher, Sylvia E.
Funding

Funding for this research was provided by:

Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM
License Information

Text and Data Mining valid from 2026-02-17

Version of Record valid from 2026-02-17
More Information

Article History

Received: 10 November 2025

Accepted: 27 November 2025

First Online: 17 February 2026

Declarations

:

: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Document is current

Any future updates will be listed below